Larimar Therapeutics
LRMR
#8139
Rank
S$0.42 B
Marketcap
S$4.05
Share price
-2.48%
Change (1 day)
-12.88%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2026 (TTM): S-$2.51

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.52. In 2025 the company made an earnings per share (EPS) of S-$2.85 a decrease over its 2024 EPS that were of S-$1.68.

EPS history for Larimar Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.51-11.93%
2025S-$2.8570%
2024S-$1.68
2022S-$1.99-48.15%
2021S-$3.83-14.27%
2020S-$4.47